ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,000 | -28.1% | 24,358 | +3.2% | 0.00% | – |
| Q2 2023 | $32,000 | -97.4% | 23,593 | -28.0% | 0.00% | -100.0% |
| Q3 2020 | $1,217,000 | +12.8% | 32,753 | +51.9% | 0.01% | 0.0% |
| Q2 2020 | $1,079,000 | +58.7% | 21,568 | -10.1% | 0.01% | +50.0% |
| Q1 2020 | $680,000 | -50.9% | 23,993 | -2.7% | 0.00% | -50.0% |
| Q4 2019 | $1,386,000 | +80.2% | 24,668 | +9.4% | 0.01% | +100.0% |
| Q3 2019 | $769,000 | -41.0% | 22,549 | -19.8% | 0.00% | -50.0% |
| Q2 2019 | $1,304,000 | +69.4% | 28,115 | +46.5% | 0.01% | +60.0% |
| Q1 2019 | $770,000 | -6.7% | 19,189 | +6.8% | 0.01% | -16.7% |
| Q4 2018 | $825,000 | +6.0% | 17,961 | +2.3% | 0.01% | 0.0% |
| Q3 2018 | $778,000 | – | 17,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |